Delivery Order SPE2DB22D3301-SPE2DB26FX4LN
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count unit) with a ceiling value of $3,734.00. This firm fixed-price delivery order is scheduled for completion by October 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units) with a ceiling value of $2,133.12. This delivery order represents a firm fixed-price, non-set-aside award and is scheduled for ultimate completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,349.67 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units). This firm fixed-price contract, with a completion date of September 9, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, demonstrating AmerisourceBergen's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) valued at $1,066.56. This non-set-aside competitive award reflects a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) at a ceiling value of $1,030.76. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units) with a ceiling value of $1,066.56. This non-set-aside, firm fixed-price delivery order is set for ultimate completion on August 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count units) with a ceiling value of $3,199.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a $1,066.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units). This non-competitive, non-set-aside delivery order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.94 to AmerisourceBergen Drug Corp for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count units). This order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,133.12 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count package). This competitively awarded, firm fixed-price delivery order is not set aside for small business and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. The contract represents a routine pharmaceutical...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4LNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a ceiling value of $1,907.60. This non-competitive, firm fixed-price delivery order is scheduled for completion by November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen Drug Corp maintains a comprehensive contract vehicle enabling it to supply a broad range of pharmaceutical products and medical supplies to support military healthcare systems globally. The company's extensive federal contract portfolio demonstrates its established capability to fulfill competitive procurement requirements across multiple therapeutic domains and customer bases within the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/6/25 |